PKU Research Development vs Cost Of Revenue Analysis

000788 Stock

6.60 0.03 0.45%

PKU HealthCare financial indicator trend analysis is much more than just breaking down PKU HealthCare Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PKU HealthCare Corp is a good investment. Please check the relationship between PKU HealthCare Research Development and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PKU HealthCare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Cost Of Revenue

Research Development vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PKU HealthCare Corp Research Development account and Cost Of Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between PKU HealthCare's Research Development and Cost Of Revenue is -0.09. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of PKU HealthCare Corp, assuming nothing else is changed. The correlation between historical values of PKU HealthCare's Research Development and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of PKU HealthCare Corp are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Research Development i.e., PKU HealthCare's Research Development and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.09

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Research Development

Cost Of Revenue

Cost of Revenue is found on PKU HealthCare Corp income statement and represents the costs associated with goods and services PKU HealthCare provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from PKU HealthCare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PKU HealthCare Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PKU HealthCare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of December 11, 2024, Selling General Administrative is expected to decline to about 317.8 M. In addition to that, Tax Provision is expected to decline to about 19.4 M

	2021	2022	2023	2024 (projected)
Cost Of Revenue	1.3B	1.3B	1.5B	1.1B
Total Revenue	2.2B	2.1B	2.2B	1.5B

Cost Of Revenue Total Revenue

PKU HealthCare fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Retained Earnings	Short Term Investments	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		0.76	0.97	0.33	0.43	0.94	0.55	0.16	0.45	-0.01	0.86	0.4	0.96	0.37	0.51	0.81	-0.24	0.12	-0.28	0.49	-0.24	0.43	-0.15	0.53	-0.49	-0.14
Other Current Liab	0.76		0.72	0.25	0.6	0.63	0.19	0.29	0.12	0.0	0.67	0.19	0.73	0.52	0.25	0.66	-0.05	-0.02	-0.32	0.28	-0.09	0.27	0.1	0.42	-0.45	-0.01
Total Current Liabilities	0.97	0.72		0.16	0.48	0.91	0.61	0.06	0.32	-0.09	0.85	0.54	0.98	0.34	0.35	0.78	-0.33	-0.02	-0.39	0.59	-0.34	0.54	-0.2	0.6	-0.56	-0.25
Total Stockholder Equity	0.33	0.25	0.16		-0.26	0.27	0.43	0.78	0.78	0.8	0.0	-0.2	0.06	0.29	0.92	-0.15	0.66	0.57	0.46	-0.53	0.46	-0.53	0.33	-0.38	0.34	0.44
Other Liab	0.43	0.6	0.48	-0.26		0.23	-0.15	-0.01	-0.28	-0.25	0.5	0.14	0.53	0.46	-0.31	0.53	-0.11	-0.46	-0.15	0.4	-0.09	0.32	-0.13	0.44	-0.42	0.01
Accounts Payable	0.94	0.63	0.91	0.27	0.23		0.51	0.05	0.46	-0.12	0.9	0.5	0.91	0.25	0.55	0.81	-0.4	0.25	-0.37	0.52	-0.41	0.51	-0.2	0.49	-0.42	-0.3
Cash	0.55	0.19	0.61	0.43	-0.15	0.51		0.16	0.48	0.39	0.23	0.5	0.47	-0.03	0.52	0.09	0.02	0.23	-0.17	0.2	-0.13	0.19	0.01	0.25	-0.25	-0.11
Other Assets	0.16	0.29	0.06	0.78	-0.01	0.05	0.16		0.55	0.78	-0.12	-0.29	-0.05	0.62	0.58	-0.28	0.8	0.31	0.59	-0.65	0.72	-0.69	0.43	-0.5	0.38	0.49
Long Term Debt	0.45	0.12	0.32	0.78	-0.28	0.46	0.48	0.55		0.48	0.26	0.01	0.25	0.33	0.85	0.02	0.39	0.62	0.41	-0.39	0.27	-0.41	-0.02	-0.42	0.4	0.3
Net Receivables	-0.01	0.0	-0.09	0.8	-0.25	-0.12	0.39	0.78	0.48		-0.38	-0.21	-0.24	0.2	0.58	-0.52	0.78	0.31	0.47	-0.66	0.59	-0.65	0.57	-0.47	0.39	0.43
Inventory	0.86	0.67	0.85	0.0	0.5	0.9	0.23	-0.12	0.26	-0.38		0.54	0.91	0.29	0.27	0.9	-0.52	0.06	-0.45	0.59	-0.54	0.59	-0.35	0.49	-0.4	-0.38
Other Current Assets	0.4	0.19	0.54	-0.2	0.14	0.5	0.5	-0.29	0.01	-0.21	0.54		0.49	-0.07	0.04	0.31	-0.53	0.02	-0.61	0.53	-0.7	0.66	-0.33	0.35	-0.2	-0.56
Total Liab	0.96	0.73	0.98	0.06	0.53	0.91	0.47	-0.05	0.25	-0.24	0.91	0.49		0.31	0.28	0.89	-0.44	-0.04	-0.43	0.67	-0.39	0.61	-0.25	0.66	-0.62	-0.27
Intangible Assets	0.37	0.52	0.34	0.29	0.46	0.25	-0.03	0.62	0.33	0.2	0.29	-0.07	0.31		0.18	0.14	0.45	0.18	0.47	-0.17	0.38	-0.29	-0.13	-0.1	0.06	0.56
Common Stock	0.51	0.25	0.35	0.92	-0.31	0.55	0.52	0.58	0.85	0.58	0.27	0.04	0.28	0.18		0.11	0.33	0.67	0.25	-0.27	0.19	-0.26	0.16	-0.21	0.22	0.18
Property Plant Equipment	0.81	0.66	0.78	-0.15	0.53	0.81	0.09	-0.28	0.02	-0.52	0.9	0.31	0.89	0.14	0.11		-0.63	-0.12	-0.51	0.75	-0.48	0.7	-0.29	0.71	-0.65	-0.37
Retained Earnings	-0.24	-0.05	-0.33	0.66	-0.11	-0.4	0.02	0.8	0.39	0.78	-0.52	-0.53	-0.44	0.45	0.33	-0.63		0.17	0.82	-0.82	0.78	-0.89	0.31	-0.65	0.56	0.79
Short Term Investments	0.12	-0.02	-0.02	0.57	-0.46	0.25	0.23	0.31	0.62	0.31	0.06	0.02	-0.04	0.18	0.67	-0.12	0.17		0.24	-0.27	0.19	-0.26	0.09	-0.25	0.24	0.18
Net Tangible Assets	-0.28	-0.32	-0.39	0.46	-0.15	-0.37	-0.17	0.59	0.41	0.47	-0.45	-0.61	-0.43	0.47	0.25	-0.51	0.82	0.24		-0.66	0.71	-0.81	-0.06	-0.6	0.55	0.82
Other Stockholder Equity	0.49	0.28	0.59	-0.53	0.4	0.52	0.2	-0.65	-0.39	-0.66	0.59	0.53	0.67	-0.17	-0.27	0.75	-0.82	-0.27	-0.66		-0.67	0.94	-0.45	0.93	-0.83	-0.51
Deferred Long Term Liab	-0.24	-0.09	-0.34	0.46	-0.09	-0.41	-0.13	0.72	0.27	0.59	-0.54	-0.7	-0.39	0.38	0.19	-0.48	0.78	0.19	0.71	-0.67		-0.78	0.51	-0.49	0.31	0.63
Long Term Investments	0.43	0.27	0.54	-0.53	0.32	0.51	0.19	-0.69	-0.41	-0.65	0.59	0.66	0.61	-0.29	-0.26	0.7	-0.89	-0.26	-0.81	0.94	-0.78		-0.35	0.84	-0.69	-0.63
Short Long Term Debt	-0.15	0.1	-0.2	0.33	-0.13	-0.2	0.01	0.43	-0.02	0.57	-0.35	-0.33	-0.25	-0.13	0.16	-0.29	0.31	0.09	-0.06	-0.45	0.51	-0.35		-0.22	0.1	-0.07
Total Current Assets	0.53	0.42	0.6	-0.38	0.44	0.49	0.25	-0.5	-0.42	-0.47	0.49	0.35	0.66	-0.1	-0.21	0.71	-0.65	-0.25	-0.6	0.93	-0.49	0.84	-0.22		-0.94	-0.37
Short Term Debt	-0.49	-0.45	-0.56	0.34	-0.42	-0.42	-0.25	0.38	0.4	0.39	-0.4	-0.2	-0.62	0.06	0.22	-0.65	0.56	0.24	0.55	-0.83	0.31	-0.69	0.1	-0.94		0.35
Non Current Assets Total	-0.14	-0.01	-0.25	0.44	0.01	-0.3	-0.11	0.49	0.3	0.43	-0.38	-0.56	-0.27	0.56	0.18	-0.37	0.79	0.18	0.82	-0.51	0.63	-0.63	-0.07	-0.37	0.35

Click cells to compare fundamentals

PKU HealthCare Account Relationship Matchups

PKU HealthCare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.5B	2.3B	2.5B	2.6B	2.4B	2.2B
Other Current Liab	154.2M	277.3M	320.9M	519.8M	1.7M	1.6M
Total Current Liabilities	1.2B	996.5M	1.1B	1.2B	968.1M	1.1B
Total Stockholder Equity	1.3B	1.3B	1.3B	1.4B	1.4B	882.7M
Other Liab	15.2M	18.2M	43.5M	24.9M	22.4M	26.7M
Accounts Payable	553.6M	419.2M	460.7M	490.9M	529.9M	458.9M
Cash	668.9M	477.0M	446.3M	633.5M	457.3M	420.0M
Other Assets	83.8M	115.2M	95.8M	83.9M	96.5M	53.3M
Net Receivables	1.4B	1.2B	1.6B	1.2B	1.2B	742.0M
Inventory	165.7M	114.6M	125.6M	172.2M	184.2M	229.7M
Other Current Assets	20.2M	19.5M	20.5M	21.2M	24.4M	36.8M
Total Liab	1.2B	1.0B	1.2B	1.3B	1.0B	1.3B
Intangible Assets	41.5M	82.2M	111.9M	132.5M	128.8M	135.2M
Property Plant Equipment	161.3M	140.3M	208.6M	212.2M	191.0M	181.4M
Retained Earnings	462.7M	501.8M	545.0M	587.3M	570.5M	430.2M
Net Tangible Assets	1.2B	1.3B	1.3B	1.3B	1.5B	1.3B
Deferred Long Term Liab	34.4M	53.0M	45.5M	30.4M	35.0M	32.5M
Short Long Term Debt	313.4M	255.3M	265.5M	127.3M	35.1M	33.3M
Total Current Assets	2.2B	2.0B	2.2B	2.2B	2.1B	1.7B
Non Current Assets Total	254.0M	286.0M	371.1M	398.2M	385.4M	333.4M
Non Currrent Assets Other	21.7M	35.0M	29.8M	31.8M	53.5M	43.5M
Non Current Liabilities Total	15.2M	18.2M	110.5M	67.4M	48.8M	36.4M
Net Invested Capital	1.6B	1.6B	1.6B	1.5B	1.5B	1.6B
Net Working Capital	1.0B	1.0B	1.1B	1.0B	1.1B	1.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in PKU Stock

Balance Sheet is a snapshot of the financial position of PKU HealthCare Corp at a specified time, usually calculated after every quarter, six months, or one year. PKU HealthCare Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of PKU HealthCare and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which PKU currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PKU Research Development vs Cost Of Revenue Analysis

Research Development vs Cost Of Revenue

Research Development vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Research Development

Cost Of Revenue

PKU HealthCare fundamental ratios Correlations

PKU HealthCare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PKU HealthCare fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in PKU Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.98	Total Current Liabilities
Total Current Liabilities	+ 0.97	Total Assets
Total Liab	+ 0.96	Total Assets
Accounts Payable	+ 0.94	Total Assets
Long Term Investments	+ 0.94	Other Stockholder Equity
Total Current Assets	+ 0.93	Other Stockholder Equity

Short Term Debt	- 0.94	Total Current Assets
Long Term Investments	- 0.89	Retained Earnings
Short Term Debt	- 0.83	Other Stockholder Equity
Other Stockholder Equity	- 0.82	Retained Earnings
Long Term Investments	- 0.81	Net Tangible Assets
Long Term Investments	- 0.78	Deferred Long Term Liab